In a significant shift in healthcare policy, major medical institutions, including NYU Langone in New York City and Baystate Health in Massachusetts, have announced the termination of gender-affirming medical treatments for transgender youth. These closures have led to widespread concern and backlash from advocacy groups focused on LGBTQ+ rights. The decisions were reportedly influenced by external pressures, including threats to funding and regulatory changes surrounding transgender care. This has left many young trans individuals in New York City and Western Massachusetts without access to vital healthcare services, including hormone therapy and gender surgeries, exacerbating fears about the future of supportive health options for this vulnerable population.